[1] BAKSHI S S.Rhino-orbital mucormycosis in a patient with diabetes[J]. Lancet Diabetes Endocrinol,2017,5(3):234. [2] YEUNG C K, CHENG V C, LIE A K, et al.Invasive disease due to Mucorales:a case report and review of the literature[J]. Hong Kong Med J,2001,7(2):180-188. [3] SAFAR A, MARSAN J, MARGLANI O, et al.Early identification of rhinocerebral mucormycosis[J]. J Otolaryngol,2005,34(3):166-171. [4] 中国医药教育协会真菌病专业委员会,中国毛霉病专家共识工作组.中国毛霉病临床诊疗专家共识(2022)[J] .中华内科杂志,2023,62(6):597-605. [5] 吴飞凤,田继东,佘周等.儿童小克银汉毛霉病的临床特征分析:1例报告并文献复习[J].南方医科大学学报,2022,42(5):780-785. [6] TALMI Y P, REONVEN A G, BAKON M, et al.Rhino-orbital and rhino-orbito-cerebral mucormycosis[J]. Otolaryngol Head Neck surg,2002,127(1): 22-31. [7] SEKARAN A, PATIL N, SABHAPANDIT S, et al.Rhino-orbito-cerebral mucormycosis: an epidemic in a pandemic[J]. IJID Reg,2022,2:99-106. [8] HOENIGL M, SEIDEL D, CARVALHO A, et al.The emergence of COVID-19 associated mucormycosis: A review of cases from 18 countries[J]. Lancet Microbe,2022,3(7):e543-e552. [9] CHUN S F S, STEVENS D A. Mucormycosis.In: BENNETT J C,PLUM F,eds. Cecil textbook of medicine[M]. 20th ed.London: Saunders,1996.1832-1834. [10] WALDORF A R, RUDERMAN N.Diamond RD specific susceptlbaity to Mucormycosisin murine diabetes and bronchoalveolar macrophage defense against Rhizopus[J]. J Clin Inveslig,1984,74(1):150-160. [11] BAWANKAR P, LAHANE S, PATHAK P, et al.Central retinal artery occlusion as the presenting manifestation of invasive rhino-orbital-cerebral mucormycosis[J]. Taiwan J Ophthalmol,2020,10(1):62-65. [12] KRISHNA V, BANSAL N, MORJARIA J, et al.COVID-19-Associated Pulmonary Mucormycosis[J]. J Fungi (Basel),2022,8(7):711. [13] CORNELY OA, ARIKAN-AKDAGLI S, DANNAOUI E, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis2013[J]. Clin Microbiol Infect,2014,20 Suppl 3:5-26. [14] SON J H, LIM H B, LEE S H, et al.Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings[J]. PLoS One,2016,11(8):e0160897. [15] KONTOYIANNIS D P, LEWIS R E.How I treat mucormycosis[J]. Blood,2011,118(5):1216-1224. [16] SEN M, LAHANE S, LAHANE T P, et al.Mucor in a Viral Land: A Tale of Two Pathogens[J]. Indian J Ophthalmol,2021,69(2):244-252. [17] HONAVAR S G.Code mucor: Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19[J]. Indian J Ophthalmol,2021,69:1361-1365. [18] DIBARTOLO M A, KELLEY P S.Rhino-orbital-cerebral mucormycosis (ROCM) : a comprehensive case review[J]. Aviat Space Environ Med,2011,82:913-916. [19] KASHYAP S, BERNSTEIN J, GHANCHI H, et al.Diagnosis of Rhinocerebral Mucormycosis by Treatment of CavernousRight Internal Carotid Artery Occlusion With Mechanical Thrombectomy: Special Case Presentation and Literature Review[J]. Front Neurol,2019,10:264. |